Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03492788 · ClinicalTrials.gov registry record · NA

Optimizing CRT With ECGI

A NA study, sponsored by Washington University School of Medicine.

Terminated
Registry status
NA
Development phase
3
Enrollment target

NCT03492788 is a NA study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 3 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03492788, a NA study, was terminated before completion, sponsored by Washington University School of Medicine.

TERMINATED
Registry status
NA
Development phase
3 participants
Enrollment target

Study Summary

CRT is delivered from two electrodes on opposite sides of the heart \[right (RV) and left ventricle (LV)\] delivering stimulation for more efficient heart beats. There is flexibility in the sequence and temporal staggering of the stimulation from these two electrodes with a different optimum for different patients. However, standard techniques to figure out the optimal stimulation strategy like standard 12-lead surface electrical recording (ECG) or routine ultrasound have failed. The investigators have developed ECG imaging (ECGI) with 250 electrode surface recording combined with CT scan to reconstruct high resolution 4-dimensional panoramic electrical maps of the heart. The study seeks to enroll 56 patients undergoing CRT in a clinical trail to evaluate short and long term impact of using ECGI for optimal programming of CRT.

Interventions

  • OTHER ECGI-optimized VV-offset
  • OTHER Zero VV-offset

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2017-12-28
Est. Completion 2018-10-05
Phase NA

What the Registry Record Tells You About NCT03492788

The ClinicalTrials.gov registry entry for NCT03492788 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which ECGI-optimized VV-offset is the first listed.

NCT03492788 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03492788 about?

NCT03492788 is a clinical study titled "Optimizing CRT With ECGI". CRT is delivered from two electrodes on opposite sides of the heart \[right (RV) and left ventricle (LV)\] delivering stimulation for more efficient heart beats. There is flexibility in the sequence and temporal staggering of the stimulation from these two electrodes with a different optimum for dif...

What is the current status of trial NCT03492788?

This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2017-12-28. Estimated completion is 2018-10-05.

What interventions are being tested in trial NCT03492788?

The interventions under investigation include: ECGI-optimized VV-offset (OTHER), Zero VV-offset (OTHER).

Who is sponsoring clinical trial NCT03492788?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.